Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay V Upreti

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|May 16, 2015
Exodus of clinical pharmacologists and pharmacometricians from academia--Who is to blame? A policy statement from the American College of Clinical PharmacologyVijay V Upreti,
Clinical Pharmacology and Therapeutics|April 18, 2019
Model-Based Meta-Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of EvidenceVijay V Upreti, Karthik Venkatakrishnan
Journal of Pharmaceutical Sciences|August 29, 2007
Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in ratVijay V Upreti, Natalie D Eddington
Journal of Clinical Pharmacology|January 13, 2018
Antibiotics Development and the Emergence of Resistance: Clinical Pharmacology to the RescueVijay V Upreti, April M Barbour
Journal of Clinical Pharmacology|July 4, 2015
Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modelingVijay V Upreti, Jan L Wahlstrom
Advances in Therapy|June 21, 2021
Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid TumorsJohannes Kast, Sandeep Dutta, Vijay V Upreti
Clinical Pharmacology in Drug Development|November 4, 2025
What Does an Editor Do in 2025?Amalia M Issa, Michael Fossler, Vijay V Upreti
Clinical Pharmacology and Therapeutics|January 29, 2024
Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA-Based Therapeutics Using a Mechanistic Physiologically-Based Pharmacokinetic-Pharmacodynamic ModelAnnie Lumen, Xinwen Zhang, Sandeep Dutta, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2021
The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancerMichael Z Liao, Hans Prenen, Sandeep Dutta, et al.
Journal of Clinical Pharmacology|September 2, 2008
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparinAlan L Myers, Vijay V Upreti, Manoj Khurana, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|May 16, 2015
Exodus of clinical pharmacologists and pharmacometricians from academia--Who is to blame? A policy statement from the American College of Clinical PharmacologyVijay V Upreti,
Clinical Pharmacology and Therapeutics|April 18, 2019
Model-Based Meta-Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of EvidenceVijay V Upreti, Karthik Venkatakrishnan
Journal of Pharmaceutical Sciences|August 29, 2007
Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in ratVijay V Upreti, Natalie D Eddington
Journal of Clinical Pharmacology|January 13, 2018
Antibiotics Development and the Emergence of Resistance: Clinical Pharmacology to the RescueVijay V Upreti, April M Barbour
Journal of Clinical Pharmacology|July 4, 2015
Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modelingVijay V Upreti, Jan L Wahlstrom
Advances in Therapy|June 21, 2021
Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid TumorsJohannes Kast, Sandeep Dutta, Vijay V Upreti
Clinical Pharmacology in Drug Development|November 4, 2025
What Does an Editor Do in 2025?Amalia M Issa, Michael Fossler, Vijay V Upreti
Clinical Pharmacology and Therapeutics|January 29, 2024
Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA-Based Therapeutics Using a Mechanistic Physiologically-Based Pharmacokinetic-Pharmacodynamic ModelAnnie Lumen, Xinwen Zhang, Sandeep Dutta, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2021
The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancerMichael Z Liao, Hans Prenen, Sandeep Dutta, et al.
Journal of Clinical Pharmacology|September 2, 2008
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparinAlan L Myers, Vijay V Upreti, Manoj Khurana, et al.
Pageof 6